A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Sabet A. N Engl J Med 2024;390:1632.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med 2024;390:1632.
PMID: 38692301